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doi:10.1016/j.ejvs.2010.02.006Abstract Objective: Cerebral embolisation constitutes the main source of complications
during transfemoral carotid artery stenting (CAS) and is associated with a high incidence of
silent brain infarction. The goal of this study is to evaluate the incidence of new ischaemic
cerebral lesions following transcervical CAS with carotid flow reversal for neuroprotection.
Materials and Methods: Thirty-one consecutive patients underwent transcervical CAS with
carotid flow reversal. A stroke scale and diffusion-weighted magnetic resonance imaging
(DW-MRI) were performed within 24 h before and after the procedure. DW-MRI studies were
compared blindly by two independent neuroradiologists. New hyper-intense DW signals were
interpreted as ischaemic infarcts. The progress of all patients was followed for at least 30 days
following intervention.
Results: All procedures were technically successful. Nineteen (61%) patients were symptom-
atic Mean carotid flow reversal time was 22 min. There were no major adverse events at 30
days. All patients remained neurologically intact without increase in the stroke scale. Thirty
subjects had paired DW-MRI studies. Post-procedural DW-MRI ischaemic infarcts were found
in four (12.5%) patients, all ipsilateral to the treated hemisphere and asymptomatic. During
follow-up, all stents remained patent and all patients remained stroke-free.u (E. Criado).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
662 J.I. Leal et al.Conclusions: These data suggest that transcervical carotid stenting with carotid flow reversal
carries a low incidence of new ischaemic infarcts, significantly lower than that reported with
transfemoral CAS. The transcervical approach with carotid flow reversal may improve the
safety of CAS and has the potential to produce results comparable to those of carotid endar-
terectomy.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Carotid endarterectomy (CEA) has been a mainstay in the
treatment of carotid artery disease and has been shown to
reduce the risk of stroke in randomised trials. Carotid
artery stenting (CAS) via a transfemoral access route offers
a new treatment option for significant carotid stenosis. The
current literature favours the use of cerebral protection
methods during CAS and suggests that cerebral protection
devices may reduce stroke rates compared with unpro-
tected CAS. However, to date no prospective trial has
proven that cerebral protection methods improve the
results of CAS, and the different available protective
methods have not been compared in a prospective fashion.
The low incidence of clinically apparent neurological
complications during CAS is in stark contrast with the high
incidence of silent brain infarction demonstrated by
diffusion-weighted magnetic resonance imaging (DW-MRI)
following the procedure. The potential relationship
between silent brain infarction and long-term deterioration
in cognitive function and/or development of dementia
remains an unresolved concern.
A recent study suggests a slightly lower incidence of post-
procedural silent infarctions when cerebral protection is
used during CAS, compared with unprotected CAS.1 Our
study was designed to evaluate prospectively the incidence
of new cerebral ischaemic lesions, as assessed by DW-MRI
during CAS, performed through a transcervical access
approach using carotid flow reversal for cerebral protection.
Materials and Methods
From April 2008 to June 2009, 31 consecutive patients with
significant carotid stenosis were included in the study. The
study inclusion criteria required an accepted indication for
carotid intervention, carotid bifurcation located at least
5 cm from the edge of the clavicle; absence of calcification
in the anterior wall of the common carotid artery and no
contraindication for DW-MRI.
The degree of carotid artery stenosis was evaluated by
ultrasonography following NASCET criteria (NASCET, The
North American Symptomatic Carotid Endarterectomy
Trial).2 Carotid plaques were categorised into echolucency
type according to Geroulakos.3 Intra-operative angiography
was used in all cases to confirm the degree of the stenosis.
All patients signed an informed consent form and the
study was conducted in accordance with the institution’s
review board for research involving human subjects
following institutional guidelines.
Surgical technique
All patients were treated preoperatively with aspirin and
clopidogrel. All procedures were performed by vascularsurgeons experienced in CAS, and done under local anaes-
thesia with clinical monitoring of neurological function.
Systemic anticoagulation was conducted before carotid
occlusion giving 100 units of intravenous heparin per
kilogram of body weight. Heparin was not reversed with
protamine at the completion of the procedure.
Our surgical technique has been published before.4
Briefly, it consists of a short incision above the edge of
the clavicle between the heads of the sternocleidomastoid
muscle. A short segment of the common carotid artery and
jugular vein are dissected, and the common carotid artery
is controlled with a Rummel loop. Eight-French sheaths are
placed in the jugular vein and the common carotid, and
connected to establish a carotid-to-jugular fistula.
Flow reversal is established and functioning of the fistula
is ascertained by arteriography, a 0.014-inch guidewire is
used to cross the carotid lesion. Before balloon dilatation,
1 mg of intravenous atropine is administered.
Lesion pre-dilatation was deemed necessary in eight
cases (26%) in which the lesion would not allow easy
passage of the stent delivery system. Pre-dilatation was
performed with carotid flow reversal using 3e4-mm, 2-cm-
long balloons inflated to 10 atm (Ultra soft SV Monorail
Balloon catheter; Boston Scientific, MA, USA). Self-
expandable Wallstents were used in 25 cases (Boston
Scientific, Massachusetts, USA) and Protege stents in six
(EV3 endovascular, Minnesota, USA). Stent selection was
based on lesion characteristics and surgeon preference. All
stents were post-dilated to 10 atm with 2-cm-long balloons
with balloon diameters ranging from 5 to 7 mm (Ultra soft
SV Monorail Balloon catheter; Boston Scientific, MA, USA).
Post-dilatation mean duration was 4 s with a standard
deviation of 2 s. Completion angiogram was done in all
cases including anteroposterior, oblique and lateral intra-
cranial projections.
After post-dilatation the introducers were withdrawn
and the vessels closed with polypropylene sutures of 5/0 or
6/0. A small Penrose drain was placed and the wound
closed with absorbable suture.
Technical failure was defined as the inability to
complete the procedure for any cause.
Neurological evaluation
DW-MRI was acquired with sagittal T1 sequences, T2 W
axial, FLAIR axial and ADC map. In addition, T1 W axial and
sagittal were conducted after contrast administration. DW-
MRIs were conducted within 24 h before and within 24e48 h
after the procedure. Pre- and post-operative DW-MRIs were
read by two independent neuroradiologists (BL and CL),
unaware of the patient’s clinical status and blinded to the
timing (pre- or post-) of the paired scans. Ischaemic lesions
Table 2 Comorbid Conditions.
n %
Hypertension 24 77.4
Diabetes Mellitus 11 35.5
Hyperlipidemia 17 54.8
Previous Myocardial Infarction 7 22.6
Smoking within last 6 months 8 25.8
Peripheral Arterial Disease 5 16.1
Silent Brain Infarction During CAS 663in both cerebral hemispheres were recorded by each reader
and compared to that of the second reader. Discrepancies
were reviewed and reconciled.
All patients were evaluated by a neurologist before and
after the procedure using the Rankin stroke scale. Neuro-
logical deficits lasting more than 24 h were defined as
stroke while those lasting less than 24 h were defined as
transient ischaemic attacks (TIAs). All patients were
reviewed 30 days after surgery, with a clinical assessment
and carotid scanning.
Results
Thirty-one consecutive patients with carotid stenosis with
a mean age of 68 years entered this study. Twenty-seven
patients were men and four women. Nineteen patients (61%)
were symptomatic,11patientswithTIAandeightwith stroke.
Five patients had a high degree of contralateral CAS and one
of these had a complete occlusion. The treated carotid was
the right in 18 cases and the left in 13. Therewere nobilateral
interventions. Carotid plaque echolucency is detailed in
Table 1. Co-morbid conditions are detailed in Table 2.
All procedures were technically successful without
(>30%) residual stenosis. The degree of carotid stenosis
assessed by arteriography was 50e70% in three patients
(all three patients were symptomatic), 70e90% in 23 and
>90% in 5. The mean operative time was 53 min (SD 5 min)
with a mean flow reversal time of 22 min (SD 4.75 min). No
neurological changes were noted during the procedure in
any patient. Following intervention, there were no strokes
or TIAs. The Rankin stroke scale did not deteriorate in any
patient and actually improved in five. No wound compli-
cations occurred in any patient.
New post-procedural DWI-MRI-detected cerebral ischae-
mic lesions were found in four subjects, all of whom had
paired DWI-MRIs. These patients developed one, two or five
ischaemic lesions in the white matter of the ipsilateral
hemisphere smaller than 5 mm in diameter without evidence
of stroke or TIA. One patient with two new ischaemic lesions
had dislodgement of the carotid sheath during the procedure
with loss of flow reversal until the sheath was replaced. The
remaining subjectshadcompletionof theprocedurewithflow
reversalmaintained throughout the intervention. Intolerance
to carotid flow reversal was not detected in any patient, even
in those with contralateral carotid stenosis >50%.
Discussion
DW-MRI is sensitive and specific in the detection of acute
cerebral ischaemia,5 revealing hyper-intense signals in theTable 1 Carotid plaque morphology according to echolu-
cency criteria.
Plaque morphology Number of plaques
Type 1 2
Type 2 9
Type 3 9
Type 4 10
Type 5 1affected areas.6 Aortic arch instrumentation during diag-
nostic procedures could produce an incidence of silent
ischaemic brain infarcts as high as 26% in the hemisphere
under study, and also in the contralateral hemisphere.7
This concerning incidence of cerebral embolisation
during carotid instrumentation prompted the study of
ischaemic brain infarction following CAS using DW-MRI.
A systematic review of the literature by Schnaudigel et
al.1 involving 1363 CAS and 754 CEA procedures suggested
evidence of new cerebral ischaemic lesions at rates of 37%
and 10% (p < 0.01), respectively. Protection devices
modestly reduce the incidence from 45% to 33%
(p < 0.010).1 The incidence of new ischaemic lesions in the
contralateral hemisphere (0.01% in CEA vs 14.5% in CAS;
p < 0.01) was significantly greater after transfemoral CAS,
suggesting embolisation during aortic arch manipulation.
The incidence of brain infarction during transfemoral CAS
and CEA is summarised in Tables 3 and 4. However, these
data are based on self-audited non-randomised case series
of protected CAS versus unprotected stenting. Data from
two recently published randomised controlled trials
comparing filter-protected versus unprotected CAS ques-
tioned routine filter use, which may be associated with
a higher incidence of new emboli after CAS compared with
control groups.42,43
Our incidence of new cerebral ischaemic lesions on
DW-MRI using transcervical CAS with carotid flow reversal
suggests that it is superior to transfemoral CAS and is
comparable to CEA. Transcervical CAS with carotid flow
reversal has a technical success rate of 97%, a zero inci-
dence of major stroke or death, a 91% stroke-free survival
at 3 years44 and a remarkable absence of embolic signals
detected by transcranial Doppler during the procedure.45
In our study population of 31 patients, 61% were symp-
tomatic. Despite our higher proportion of symptomatic
patients, the 30-day major neurological complication rate
remained zero. Similar to the experience with carotid
endarterectomy, we did not observe new infarcts in the
contralateral hemisphere during our study. This most likely
reflects the lack of aortic arch and proximal supra-aortic
trunk manipulation.
Current transfemoral stenting experiences exhibit rates
of emboli as high as 70% which can be improved by mini-
mising trauma during access.29,46
Proximal protection devices, delivered transfemorally,
use the same reverse flow protection as the technique we
describe. However, they require manipulation in the aortic
arch, great vessels and carotid bulb during periods of the
procedure when there is no cerebral protection. In
comparison, our technique uses a low cervical incision,
Table 3 Incidence of Ischemic Infarction with Carotid Artery Stenting.
Author Year Procedures (N) Strokes (N) New Ischemic lesions on DW-MRI
Ipsilateral Contralateral Any
Lovblad8 2000 19 2 4 (21,05%)
Jaeger9 2001 20 0 3 2 5(25 %)
Jaeger10 2002 70 1 20 6 26 (37,14%)
Schluter11 2003 44 1 8 2 10 (22,72%)
Gauvrit12 2004 22 1 2 0 2 (9,09%)
Poppert13 2004 41 1 22 4 22 (53,65%)
Flach14 2005 21 1 9 2 9 (42,85%)
Roh15 2005 18 2 8 (44,44%)
Cossottini16 2005 52 1 16 (30,76%)
Hammer17 2005 53 2 14 13 21 (39,62%)
Hauth18 2005 105 0 22 (20,95%)
Rosenkranz19 2006 27 0 6 2 8 (29,62%)
Du Mesnil20 2006 50 1 14 7 19 (38%)
Maleux21 2006 53 0 17 10 22 (41,50%)
McDonell22 2006 107 8 23 (21,49%)
Pinero23 2006 162 1 22 9 28 (17,28%)
Kastrup24 2006 206 11 113 38 126 (61,16%)
Asakura25 2006 45 1 14 13 20 (44,44%)
Iihara26 2006 92 7 32 (34,78%)
Grunwald27 2006 10 0 3 1 4 (40%)
Rapp28 2007 54 2 35 11 36 (59,01%)
Lacroix29 2007 61 2 20 10 26 (42,62%)
Tedesco30 2007 27 2 16 10 19 (70,37%)
Skelland31 2009 30 2 6 0 6 (20%)
Taha32 2009 98 3 35 20 42 (42,85%)
664 J.I. Leal et al.thereby avoiding the arch manipulation risk, and eliminates
instrumentation for external carotid artery occlusion.
Additionally, it also reduces the risk of complications
associated with CEA.
The clinical significance of the appearance of post-
procedural silent ischaemic cerebral lesions is unknown.Table 4 Incidence of Ischemic Infarction with Carotid Endarter
Author Year Procedures (N) Strokes (
Jansen33 1994 40 1
Cantelmo34 1998 78 1
Barth35 2000 48 0
Feiwell36 2001 25 0
Forbes37 2001 18 1
Tomczak38 2001 51 0
Mu¨ller39 2003 33 1
Wolf40 2004 33 1
Poppert13 2004 88 2
Flach14 2004 23 2
Roh15 2005 26 1
Iihara25 2006 139 3
Inoue41 2006 72 1
Lacroix28 2007 60 2
Tedesco29 2007 20 0
Skejelland30 2009 61 0Very few studies have described the long-term fate of post-
operative DWI-detected ischaemic lesions. Whether these
silent ischaemic lesions cause permanent brain damage
with cognitive impairment or merely transient sequelae
remains unclear. Indeed, some of these lesions may resolve
within months, as reported in other series.47 However,ectomy.
N) New Ischemic lesions on DWI
Ipsilateral Contralateral Any
4 0 4 (10%)
7 0 7 (8,97%)
2 0 2 (4,17%)
1 0 1 (4%)
0 0 0 (0 %)
6 0 6 (11,76%)
9 (27,28%)
8 0 8 (24,25%)
15 0 15 (17,04%)
2 0 2 (8,69%)
1 0 1 (3,85%)
13 (9,36%)
3 (4,17%)
7 1 7 (11,67%)
0 0 0 (0%)
2 0 2 (3,28%)
Silent Brain Infarction During CAS 665anatomical resolution may not be necessarily associated
with absence of neurological sequelae.
In the absence of stroke or TIA, we do not know whether
permanent cerebral damage follows these lesions, although
there is increasing evidence that silent cerebral infarction
is associated with a higher risk of long-term cognitive
deterioration or development of dementia probably in
predisposed individuals.48
Unfortunately, we were not able to include a standard
cognitive assessment of our patients before and after the
study to measure changes in this rather unexplored brain
function. However, our low incidence of new ischaemic
lesions and the small patient sample does not allow estab-
lishing correlations between potential risk factors for cere-
bral embolisation and long-term neurological changes. Our
data strongly suggest that transcervical carotid stenting
with flow reversal may produce a significantly lower inci-
dence of cerebral embolisation than currently obtained with
conventional transfemoral carotid stenting procedures.
Conclusions
Carotid stenting using a transcervical approach with cere-
bral flow reversal is a very safe procedure with a very low
incidence of major adverse events. The remarkably low
incidence of silent brain infarctions appearing after the
procedure suggests that this technique may be safer than
the transfemoral approach The low incidence of major
adverse events and silent brain infarction obtained with
transcervical carotid artery stenting with carotid flow
reversal may be comparable to that obtained with the best
results of carotid endarterectomy via a minor low incision
which avoids cranial nerve injury and general anaesthesia.
This study was funded in part by Silk Road Medical, Inc.
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